WebGraham Maureen, Dr Diamond Biopharm Limited UK [email protected] Green Sue, Mrs Cardiome UK limited UK [email protected]; Gregory Gillian, Mrs Gregory Fryer Associates Ltd UK [email protected]; Groenewegen Dirk, DR Glycostem Therapeutics Netherland … WebOn 14 December 2015, orphan designation (EU/3/15/1587) was granted by the European Commission to Diamond BioPharm Limited, United Kingdom, for combretastatin A1 diphosphate for the treatment of acute myeloid leukaemia. The sponsorship was transferred to Diamond ROC EOOD, Bulgaria, in March 2024.
Diamond Pharma Services - Overview, News & Competitors
WebVeterinary Pharmaceutical Submissions in the EU (European Union) Training Course Presentations will cover the regulatory framework, pharmaceutical, toxicological and pharmacological data, safety risk assessments, pre-clinical and clinical data, detailed and critical summaries and regulatory submissions. WebNov 22, 2015 · Diamond Biopharm is one of very few European regulatory companies which has experience in clinical and regulatory development programmes within the gene therapy sector, to an advanced stage of development. Its first European Marketing Authorisation Application submission for a gene therapy product will be in 2009. sickness policy childcare
Diamond Pharma
WebDiamond BioPharm Limited, UK 30 Contact:No 4 East Wing, Gemini House Flex Meadow, Harlow, Essex CM19 5TJ, UK Email: [email protected] Tel: +44 … WebThe sponsorship was transferred to Diamond BioPharm Limited, United Kingdom, in October 2024. The sponsorship was transferred to Voisin Consulting S.A.R.L, France, in September 2024. The sponsorship was transferred to PTC Therapeutics International Limited, Ireland, in December 2024. WebFeb 25, 2015 · Diamond Pharma Services, Inc. was founded in February 2015 as a subsidiary of Diamond BioPharm Ltd., with offices in Boston, Massachusetts and … sickness policy ey